905
Views
2
CrossRef citations to date
0
Altmetric
Research paper

Long non-coding RNA FAM230B is a novel prognostic and diagnostic biomarker for lung adenocarcinoma

, , & ORCID Icon
Pages 7919-7925 | Received 18 Nov 2021, Accepted 21 Jan 2022, Published online: 15 Mar 2022

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019 Jan;69(1):7–34.
  • Bade BC, Dela Cruz CS. Lung Cancer 2020: epidemiology, Etiology, and Prevention. Clin Chest Med. 2020 Mar;41(1):1–24.
  • Yang D, Liu Y, Bai C, et al. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett. 2020 Jan 1;468:82–87.
  • Lu T, Yang X, Huang Y, et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res. 2019;11:943–953.
  • Shin H, Oh S, Hong S, et al. Early-Stage Lung Cancer Diagnosis by Deep Learning-Based Spectroscopic Analysis of Circulating Exosomes. ACS Nano. 2020 May 26;14(5):5435–5444.
  • Reck M, Rabe KF. Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2017 Aug 31;377(9):849–861.
  • Popper HH. Progression and metastasis of lung cancer. Cancer Metastasis Rev. 2016 Mar;35(1):75–91.
  • Riihimäki M, Hemminki A, Fallah M, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014 Oct;86(1):78–84.
  • Del Ciello A, Franchi P, Contegiacomo A, et al. Missed lung cancer: when, where, and why? Diagn Interv Radiol. 2017 Mar-Apr;23(2):118–126.
  • Duma N, Santana-Davila R, Molina JR. Non-Small Cell Lung Cancer: epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc. 2019 Aug;94(8):1623–1640.
  • Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018 Jan 24;553(7689):446–454.
  • Barnes PJ. Cellular and molecular mechanisms of asthma and COPD. Clin Sci. 2017 Jul 1;131(13):1541–1558.
  • Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017 Oct 12;36(41):5661–5667.
  • Zhang Y, Tang L. The Application of lncRNAs in Cancer Treatment and Diagnosis. Recent Pat Anticancer Drug Discov. 2018;13(3):292–301.
  • Cui Y, Pu R, Ye J, et al. LncRNA FAM230B Promotes Gastric Cancer Growth and Metastasis by Regulating the miR-27a-5p/TOP2A Axis. Dig Dis Sci. 2021 Aug;66(8):2637–2650.
  • Zhou Q, Feng J, Yin S, et al. LncRNA FAM230B promotes the metastasis of papillary thyroid cancer by sponging the miR-378a-3p/WNT5A axis. Biochem Biophys Res Commun. 2021 Mar 26;546:83–89.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001 Dec;25(4):402–408.
  • Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982 Apr;143(1):29–36.
  • Liu Z, Sun D, Zhu Q, et al. The screening of immune-related biomarkers for prognosis of lung adenocarcinoma. Bioengineered. 2021 Dec;12(1):1273–1285.
  • Ren J, Wang A, Liu J, et al. Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma. Bioengineered. 2021 Dec;12(1):4331–4348.